NL-OMON38930
Withdrawn
Not Applicable
Subcutaneous implantable cardioverter-defibrillator screening ECG during exercise in patients vulnerable for T-wave oversensing - S-ICD ECG during exercise in patients vulnerable for T-wave oversensing
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- heart rhythm disturbances
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 100
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Young patients \<40 yrs, patients with inherited arrhythmogenic syndromes (Brugada syndrome, long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, hypertrophic cardiomyopathy and idiopathic VF, such as carriers of the DPP6 haplotype), patients with a QRS duration between 100 and 150ms on baseline ECG, patients with large T\-waves on baseline ECG and other patients vulnerable for T\-wave oversensing according to the literature
Exclusion Criteria
- •Younger than 18 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Inappropriate implantable cardioverter-defibrillator therapy: Frequency, syncope and prognostic factorsife-threatening arrhythmiaJPRN-UMIN000025995Fujita Health University School of Medicine200
Recruiting
Not Applicable
ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Studyheart rhythm disturbancesventricular fibrillation10007521NL-OMON54505Medtronic BV30
Active, not recruiting
Phase 3
EV ICD Japan StudyDeveloping, life-threatening ventricular tachyarrhythmiasJPRN-jRCT2032220135Yamamoto Takuto15
Recruiting
Phase 3
ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Japan StudyJPRN-UMIN000039469Medtronic Japan Co., Ltd.15
Not yet recruiting
Not Applicable
The efficacy of subcutaneous implantable cardioverter defibrillator for primary prevention of sudden cardiac death in patients with chronic kidney disease.KCT0005596Keimyung University Dongsan Medical Center77